Vera Therapeutics Statistics

Total Valuation

VERA has a market cap or net worth of $2.27 billion. The enterprise value is $1.92 billion.

Market Cap	2.27B
Enterprise Value	1.92B

Important Dates

The last earnings date was Thursday, May 9, 2024, before market open.

Earnings Date	May 9, 2024
Ex-Dividend Date	n/a

Share Statistics

VERA has 54.92 million shares outstanding. The number of shares has increased by 35.32% in one year.

Shares Outstanding	54.92M
Shares Change (YoY)	+35.32%
Shares Change (QoQ)	+14.66%
Owned by Insiders (%)	7.91%
Owned by Institutions (%)	104.11%
Float	36.11M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	6.42
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 28.63, with a Debt / Equity ratio of 0.15.

Current Ratio	28.63
Quick Ratio	n/a
Debt / Equity	0.15
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-18.57

Financial Efficiency

Return on equity (ROE) is -52.40% and return on invested capital (ROIC) is -25.04%.

Return on Equity (ROE)	-52.40%
Return on Assets (ROA)	-39.10%
Return on Capital (ROIC)	-25.04%
Revenue Per Employee	n/a
Profits Per Employee	-$1.85M
Employee Count	51
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, VERA has paid $1,000 in taxes.

Income Tax	1,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +445.32% in the last 52 weeks. The beta is 1.11, so VERA's price volatility has been higher than the market average.

Beta (1Y)	1.11
52-Week Price Change	+445.32%
50-Day Moving Average	42.01
200-Day Moving Average	25.70
Relative Strength Index (RSI)	48.34
Average Volume (30 Days)	990,517

Short Selling Information

The latest short interest is 6.80 million, so 12.39% of the outstanding shares have been sold short.

Short Interest	6.80M
Short Previous Month	6.31M
Short % of Shares Out	12.39%
Short % of Float	18.84%
Short Ratio (days to cover)	5.57

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-101.87M
Pretax Income	-94.30M
Net Income	-94.30M
EBITDA	-92.37M
EBIT	-89.48M
Earnings Per Share (EPS)	-$2.05

Full Income Statement

Balance Sheet

The company has $403.66 million in cash and $53.26 million in debt, giving a net cash position of $350.40 million or $6.38 per share.

Cash & Cash Equivalents	403.66M
Total Debt	53.26M
Net Cash	350.40M
Net Cash Per Share	$6.38
Equity / Book Value	353.54M
Book Value Per Share	6.44
Working Capital	401.83M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$99.72 million and capital expenditures -$63,000, giving a free cash flow of -$99.78 million.

Operating Cash Flow	-99.72M
Capital Expenditures	-63,000
Free Cash Flow	-99.78M
FCF Per Share	-$1.96

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

VERA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-35.32%
Shareholder Yield	-35.32%
Earnings Yield	-4.15%
FCF Yield	-4.40%

Dividend Details

Analyst Forecast

The average price target for VERA is $36.71, which is -11.31% lower than the current price. The consensus rating is "Strong Buy".

Price Target	$36.71
Price Target Difference	-11.31%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1